What's new in pharma

February 28, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Jim Lo Scalzo - Pool/Getty Images Opinion: To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully Trump has the power to advance a "virtuous circle" of innovation to help those with rare genetic diseases, cancer, Alzheimer's, and many other maladies. By John F. Crowley RFK Jr. moves to eliminate public comment on HHS decisions In notice to Federal Register, Kennedy says public participation is not needed in many decisions by the giant health agency. By Isabella Cueto STAT+ | Ginkgo further scales back Boston real estate Subleasing space is part of an overall restructuring and cost-cutting effort by Ginkgo, the once high-flying cell production company. By Catherine Carlock — Boston Globe Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser